Weed Gummies Recall Update as Three Potential Deaths Reported

The U.S. Food and Drug Administration (FDA) has linked Diamond Shruumz-brand chocolate bars, cones and gummies to 180 illnesses, 73 hospitalizations, and three potential deaths across 34 states.
Despite a nationwide recall initiated in June 2024, the products may still be sold in some retail and online locations, prompting a renewed warning from health officials on Friday.
As the FDA has recommended, all flavors of Diamond Shruumz-brand products have been recalled, including their Microdosing Chocolate Bars, Infused Cones, and Micro-Dose and Mega-Dose/Extreme Gummies.
“These products have been recalled and should no longer be available for sale,” the FDA stated in its November 15 update.
The Diamond Shruumz products, marketed as containing psychoactive mushroom blends, were found to contain dangerous compounds, including psilocin, acetylpsilocin, muscimol, and pregabalin, according to FDA testing.
“People who became ill after eating Diamond Shruumz-brand products reported a variety of severe symptoms, including seizures, central nervous system depression (loss of consciousness, confusion, sleepiness), agitation, abnormal heart rates, hyper/hypotension, nausea, and vomiting,” the FDA added.
The products’ candy-like appearance further raises concerns about accidental consumption, particularly among children. The FDA urged parents and caregivers to safely dispose of these items and educate young people about their dangers.
Diamond Shruumz products were widely distributed online and through smoke shops and stores selling cannabidiol (CBD) and delta-8 tetrahydrocannabinol (delta-8 THC). Despite the recall, the FDA has received reports that some retailers continue to stock the products.
“These products have a long shelf life and may still be available despite the recall,” the agency warned. Consumers are encouraged to report any instances of continued sales to the FDA.
Georgia reported the highest number of cases (21), followed by Texas (19) and North Carolina (12). A total of 118 illnesses were directly linked to Diamond Shruumz products, with others associated with similar mushroom-infused edibles.
The FDA advises consumers to discard any remaining Diamond Shruumz products or return them to the company for a refund. Individuals experiencing symptoms after consuming the products should seek medical attention and contact the Poison Help Line at 1-800-222-1222.
Retailers are instructed to remove the products from shelves, secure unsold inventory, and contact the FDA for disposal instructions.
While the FDA investigation has transitioned to post-incident monitoring, authorities emphasize that public awareness remains critical. “Consumers should avoid any products marketed as psychoactive or containing mushroom extracts,” the FDA stated.
A list of store names and locations where the recalled products were available for retail sale is included in the recall announcement.